+

WO2002029049A3 - Regulation du transporteur de monoamine humain dependant du sodium - Google Patents

Regulation du transporteur de monoamine humain dependant du sodium Download PDF

Info

Publication number
WO2002029049A3
WO2002029049A3 PCT/EP2001/011441 EP0111441W WO0229049A3 WO 2002029049 A3 WO2002029049 A3 WO 2002029049A3 EP 0111441 W EP0111441 W EP 0111441W WO 0229049 A3 WO0229049 A3 WO 0229049A3
Authority
WO
WIPO (PCT)
Prior art keywords
monoamine transporter
human sodium
regulation
dependent monoamine
dependent
Prior art date
Application number
PCT/EP2001/011441
Other languages
English (en)
Other versions
WO2002029049A2 (fr
Inventor
Yonghong Xiao
Original Assignee
Bayer Ag
Yonghong Xiao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Yonghong Xiao filed Critical Bayer Ag
Priority to AU2001293863A priority Critical patent/AU2001293863A1/en
Publication of WO2002029049A2 publication Critical patent/WO2002029049A2/fr
Publication of WO2002029049A3 publication Critical patent/WO2002029049A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Selon l'invention, les réactifs régulant le transporteur de monoamine humain dépendant du sodium et les réactifs qui se lient au produits génétiques du transporteur de monoamine humain dépendant du sodium peuvent jouer un rôle dans la prévention, l'amélioration ou la correction de dysfonctionnements ou de maladies du système nerveux central.
PCT/EP2001/011441 2000-10-05 2001-10-04 Regulation du transporteur de monoamine humain dependant du sodium WO2002029049A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001293863A AU2001293863A1 (en) 2000-10-05 2001-10-04 Regulation of human sodium-dependent monoamine transporter

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23768100P 2000-10-05 2000-10-05
US60/237,681 2000-10-05

Publications (2)

Publication Number Publication Date
WO2002029049A2 WO2002029049A2 (fr) 2002-04-11
WO2002029049A3 true WO2002029049A3 (fr) 2002-11-28

Family

ID=22894719

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011441 WO2002029049A2 (fr) 2000-10-05 2001-10-04 Regulation du transporteur de monoamine humain dependant du sodium

Country Status (2)

Country Link
AU (1) AU2001293863A1 (fr)
WO (1) WO2002029049A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8141601B2 (en) 2008-10-02 2012-03-27 Roche Diagnostics Operations, Inc. Manual filling aid with push button fill

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031539A1 (fr) * 1994-05-16 1995-11-23 Human Genome Sciences, Inc. Vehicule de neurotransmetteur
WO2001057276A2 (fr) * 2000-02-04 2001-08-09 Aeomica, Inc. Sondes d'acide nucleique a un seul exon derivees du genome humain utiles pour analyser l'expression genique dans la moelle osseuse humaine
WO2001075067A2 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031539A1 (fr) * 1994-05-16 1995-11-23 Human Genome Sciences, Inc. Vehicule de neurotransmetteur
WO2001057276A2 (fr) * 2000-02-04 2001-08-09 Aeomica, Inc. Sondes d'acide nucleique a un seul exon derivees du genome humain utiles pour analyser l'expression genique dans la moelle osseuse humaine
WO2001075067A2 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI, HINXTON, UK; 1 May 2000 (2000-05-01), "Homo sapiens chromosome 19 clone CTC-301O7, complete sequence.", XP002210702, Database accession no. AC011450 *
DATABASE GENSEQ [online] Derwent; 13 February 2002 (2002-02-13), "Novel human diagnostic protein #16774.", XP002210704, Database accession no. ABG16783 *
DATABASE GENSEQ [online] Derwent; 13 February 2002 (2002-02-13), DRMANAC ET AL.: "DNA encoding novel human diagnostic protein #16774.", XP002210703, Database accession no. AAS80970 *
DATABASE GENSEQ [online] Derwent; 6 November 2001 (2001-11-06), PENN ET AL.: "Human bone marrow expressed single exon probe SEQ ID NO: 12101.", XP002210705, Database accession no. AAK37544 *

Also Published As

Publication number Publication date
AU2001293863A1 (en) 2002-04-15
WO2002029049A2 (fr) 2002-04-11

Similar Documents

Publication Publication Date Title
WO2002059621A3 (fr) Regulation de transthyretine afin de traiter l'obesite
WO2002036783A3 (fr) Regulation de l'histone deacetylase chez l'homme
WO2002030970A3 (fr) Regulation de l'histone deacetylase humaine
WO2002070675A3 (fr) Regulation de l'histone acetyltransferase humaine
WO2002020731A3 (fr) Regulation de l'enzyme humaine du type proteine disulfide isomerase
WO2002072824A3 (fr) Regulation du canal potentiel humain du recepteur transitoire humain
WO2002029049A3 (fr) Regulation du transporteur de monoamine humain dependant du sodium
WO2001077149A3 (fr) Regulation d'une proteine gpcr type cyslt2 humaine
WO2002048325A3 (fr) Regulation de la serine palmitoyltransferase humaine
WO2002081705A3 (fr) Regulation de la proteine humaine de type acetyltransferase gnat
WO2002088362A3 (fr) Regulation d'une proteine semblable a la prostaglandine-f synthase 1 humaine
WO2002033080A3 (fr) Regulation du recepteur humain membranaire liant la netrine unc5h-1
WO2002055712A3 (fr) Regulation de l'alanine aminotransferase humaine
WO2002048358A3 (fr) Regulation du recepteur humain de type chimiokine
WO2002033097A3 (fr) Regulation de la sulfotransferase humaine
WO2002036781A3 (fr) Regulation de la glutathione-s-transferase humaine
WO2002032938A3 (fr) Regulation de la proteine humaine de type pgc-1
WO2002053756A3 (fr) Regulation de glucosamine-6-phosphate desaminase humaine
WO2002052020A3 (fr) Regulation de carboxypeptidase a humaine
WO2002051996A3 (fr) Regulation de proteine humaine du type cyclophiline
WO2002072825A3 (fr) Regulation de la proteine humaine de type mrp5
WO2002062975A3 (fr) Regulation de la proteine humaine du type elongase hselo1
WO2002024731A3 (fr) Regulation de proteine humaine de type fgd1
WO2002029048A3 (fr) Regulation du transporteur du neurotransmetteur humain induit par le sodium
WO2001070954A3 (fr) Regulation du recepteur couple a la proteine g liee au facteur de croissance neuronale humain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10398119

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载